Delivery Order SPE2DB22D9239-SPE2DB23FDG29
- Not listed
- This firm fixed price delivery order was awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product EXPAREL 133 MG/10 ML VIAL 10ML. The order has a potential value of $8,566.92 and a completion date of January 29, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products to the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML, with a potential value of $2,291.36. The order has a completion date of February 12, 2024 and was awarded on January 22, 2024. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that holds multiple contracts and indefinite delivery vehicles (IDVs) with DLA to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, with a potential value of $4,108.20. The completion date for this order is February 9, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles to provide a wide range of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $27,404.34 delivery order is for the pharmaceutical product EXPAREL 133 MG/10 ML VIAL 10ML. The order has a completion date of February 5, 2024 and was awarded on January 12, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract with DLA to provide a variety of pharmaceutical and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the pharmaceutical product EXPAREL 266 MG/20 ML VIAL 20ML, with a potential value of $9,948.88 and a completion date of January 29, 2024. DMS Pharmaceutical Group holds a variety of federal contracts and indefinite delivery vehicles with DLA to supply pharmaceuticals and medical products in support of military treatment...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product EXPAREL 266 MG/20 ML VIAL 20ML. This delivery order is valued at $4,974.44 and has a completion date of January 29, 2024. DMS Pharmaceutical Group holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products to the Department of Defense and its...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4563452317 EXPAREL 133 MG/10 ML VIAL 10ML. The order has a completion date of February 9, 2024 and a potential value of $3,437.04. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds multiple contracts and indefinite delivery vehicles (IDVs) with the Defense Logistics Agency to supply a wide range of...
- This is a $7,461.66 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, to be delivered by July 15, 2024. DMS Pharmaceutical Group Inc. is the prime contractor and there are no noted subcontractors. This order is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $499,999,999, which allows the DLA to issue...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the pharmaceutical product EXPAREL 266 MG/20 ML VIAL 20ML, with a potential value of $4,974.44 and a completion date of February 2, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drugs to the federal government, particularly...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $5,021.26 order is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The order has a completion date of May 19, 2025 and is placed under a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA that allows the agency to issue delivery orders for a range of pharmaceutical items to support military...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB23FDG29Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML pharmaceutical products, with a potential value of $149,286.60. The order has a completion date of February 16, 2023 and was awarded on January 26, 2023. DMS Pharmaceutical Group holds a variety of federal contracts and indefinite delivery vehicles (IDVs) to supply pharmaceuticals and medical products in support of military treatment facilities worldwide, including specialized pharmaceutical items such as testosterone gel, human albumin, and contraceptive implants. This specific delivery order is issued against a larger indefinite delivery contract with the Defense Logistics Agency to provide a range of medical supplies with a potential value up to $5 million through December 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $149.3k | 1/26/23 |